O
OrbiMed Portfolio holdings
AUM
$3.98B
This Quarter Return
-3.5%
1 Year Return
+13.05%
3 Year Return
+159.74%
5 Year Return
+207.27%
10 Year Return
+1,027.33%
AUM
$4.82B
AUM Growth
+$4.82B
(-12%)
Cap. Flow
-$176M
Cap. Flow
% of AUM
-3.65%
Top 10 Holdings %
Top 10 Hldgs %
44.7%
Holding
132
New
19
Increased
23
Reduced
22
Closed
17
Top Buys
| 1 |
UPB
Upstream Bio, Inc. Common Stock
UPB
|
$93.6M |
| 2 |
Neurocrine Biosciences
NBIX
|
$86.8M |
| 3 |
Edwards Lifesciences
EW
|
$84.8M |
| 4 |
Alnylam Pharmaceuticals
ALNY
|
$38.9M |
| 5 |
Cytokinetics
CYTK
|
$38.4M |
Top Sells
| 1 |
Amgen
AMGN
|
$81.3M |
| 2 |
Elevance Health
ELV
|
$55.2M |
| 3 |
Merck
MRK
|
$48.4M |
| 4 |
Regeneron Pharmaceuticals
REGN
|
$47.5M |
| 5 |
Evolent Health
EVH
|
$47.1M |
Sector Composition
| 1 | Healthcare | 98.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
BiomX
PHGE
$14.3M
| $1.31M | 0.03% | 1,787,767 | – | – |
|
102
Kezar Life Sciences
KZR
$28.9M
| $1.29M | 0.03% | 192,700 -1,734,300 | -90% | -$11.7M |
|
103
Korro Bio
KRRO
$217M
| $1.23M | 0.03% | +32,400 | New | +$1.23M |
|
104
Alto Neuroscience
ANRO
$99.6M
| $1.06M | 0.02% | +250,000 | New | +$1.06M |
|
105
NextCure
NXTC
$13.5M
| $880K | 0.02% | 1,141,200 | – | – |
|
106
Agios Pharmaceuticals
AGIO
$2.19B
| $877K | 0.02% | +26,700 | New | +$877K |
|
|
ELEV
107
DELISTED
Elevation Oncology
ELEV
| $530K | 0.01% | 941,275 | – | – |
|
108
Invivyd
IVVD
$204M
| $509K | 0.01% | 1,149,300 -579,000 | -34% | -$257K |
|
|
LSB
109
LakeShore Biopharma
LSB
$33M
| $486K | 0.01% | +140,428 | New | +$486K |
|
110
Xeris Biopharma Holdings
XERS
$1.26B
| $273K | 0.01% | 80,420 | – | – |
|
111
Acadia Pharmaceuticals
ACAD
$4.38B
| – | – | -764,600 | Closed | -$11.8M |
|
|
112
Amgen
AMGN
$155B
| – | – | -252,300 | Closed | -$81.3M |
|
113
Apogee Therapeutics
APGE
$2.17B
| – | – | -379,130 | Closed | -$22.3M |
|
114
Apellis Pharmaceuticals
APLS
$3.48B
| – | – | -1,270,400 | Closed | -$36.6M |
|
115
BioNTech
BNTX
$24B
| – | – | -103,000 | Closed | -$12.2M |
|
|
116
Elevance Health
ELV
$71.8B
| – | – | -106,200 | Closed | -$55.2M |
|
|
117
Evolent Health
EVH
$1.12B
| – | – | -1,665,115 | Closed | -$47.1M |
|
118
Icon
ICLR
$13.8B
| – | – | -123,900 | Closed | -$35.6M |
|
119
Lexicon Pharmaceuticals
LXRX
$400M
| – | – | -11,024,000 | Closed | -$17.3M |
|
120
Moderna
MRNA
$9.37B
| – | – | 0 | – | – |
|
121
Oscar Health
OSCR
$4.31B
| – | – | -351,618 | Closed | -$7.46M |
|
122
Vaxcyte
PCVX
$4B
| – | – | -387,000 | Closed | -$44.2M |
|
123
Pfizer
PFE
$141B
| – | – | 0 | – | – |
|
124
Phathom Pharmaceuticals
PHAT
$864M
| – | – | -1,449,073 | Closed | -$26.2M |
|
|
125
Regeneron Pharmaceuticals
REGN
$61.5B
| – | – | -45,200 | Closed | -$47.5M |
|